Skip to main content
SpringerLink
Log in

Prostate cancer metastasis: Talking the walk

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Thymosin β15 is a positive regulator of cell motility that may prove useful as a marker of metastatic potential in prostate cancer (pages 1322–1328).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Partin, A.W., Shoeniger, J.S., Mohler, J.L. & Coffey, D.S. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc. Natl. Acad. Sci. USA 86, 1254–1258 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bao, L. et al. Thymosin β15: A novel regulator of cell tumor motility upregulated in metastatic prostate cancer. Nature Med. 2, 1322–1328 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. Stossel, T.P. On the crawling of animal cells. Science 260, 1086–1094 (1993).

    Article  CAS  PubMed  Google Scholar 

  4. Morton, R.A., Ewing, C.M., Nagafuchi, A., Tsukiata, S. & Isaacs, W.B. Reduction of Ecadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res. 53, 3585–3590 (1993).

    CAS  PubMed  Google Scholar 

  5. Umbas, R. et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancers. Cancer Res. 52, 5104–5109 (1992).

    CAS  PubMed  Google Scholar 

  6. Ben-Ze'ev, A., Fernandez, J.L.R., Geiger, B., Zoller, M. & Gluck, U. Cytoskeletal plaque proteins as regulators of cell motility and tumor suppressors. in Cell Mechanics and Cellular Engineering (eds. Mow, V.C., Guilak, F., Tran-Son-Tay, R. & Hochmuth, R.M.) 273–293 (Springer-Verlag, New York, 1994).

    Chapter  Google Scholar 

  7. Liotta, L.A. Cancer cell invasion and metastasis. Sci. Am. 266(Feb.) 54–63 (1992).

    Article  CAS  PubMed  Google Scholar 

  8. Liotta, L.A. et al. Tumor cell autocrine motility factor. Proc.Natl.Acad.Sci.USA 83, 3302–3306 (1986).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dong, J.-T. et al. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884–888 (1995).

    Article  CAS  PubMed  Google Scholar 

  10. Mohler, J.L. et al. Detection of candidates for cancer cell motility inhibitor protein in the Dunning adenocarcinoma model. Clin.Exp.Metastasis 13, 774–780 (1995).

    Article  Google Scholar 

  11. Dong, J-T. et al. Down-regulation of the KAI-1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56, 4387–4390 (1996).

    CAS  PubMed  Google Scholar 

  12. Pienta, K.J. & Coffey, D.S. Cell motility as a chemotherapeutic target. Cancer Surv. 11, 255–263 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, 21287-2101, USA

    Donald S. Coffey

Authors
  1. Donald S. Coffey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coffey, D. Prostate cancer metastasis: Talking the walk. Nat Med 2, 1305–1306 (1996). https://doi.org/10.1038/nm1296-1305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1296-1305

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation